J. Vandenbroucke

H. Schønheyder, C. Vandenbroucke-Grauls, M. Søgaard, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

No increase in mortality and morbidity among carriers of the C282Y mutation of the hereditary haemochromatosis gene in the oldest old: the Leiden 85‐plus Study

P. H. Moghaddam, A. D. de Craen, P. Slagboom, 2002, European journal of clinical investigation.

Synergy between thinness and intensive sports activity in delaying menarche.

H. Valkenburg, J. Vandenbroucke, A. van Laar, 1982, British medical journal.

UvA-DARE ( Digital Academic Repository ) Experience with multiple control groups in a large population-based case-control study on genetic and environmental risk factors

S. Cessie, F. Rosendaal, J. Vandenbroucke, 2010 .

Impact of a lifestyle intervention among subjects with the metabolic syndrome in a primary health care setting: evidence from a regression discontinuity design

S. Cessie, J. Vandenbroucke, N. Tjeerdema, 2015 .

Mortality in hereditary antithrombin-lll def iciency—1830 to 1989 F. R. ROSENDAAL H. HEIJBOER E. BRIET H. R. BÜLLER

D. Hommes, J. Vandenbroucke, D. Brandjes, 1991 .

Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group.

J. V. D. van der Meer, J. Vandenbroucke, E. M. de Kleijn, 1997, Medicine.

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

F. Rosendaal, E. Briët, J. Vandenbroucke, 1993, The Lancet.

Evolution of blood ammonia after venipuncture

J. Vandenbroucke, J. Groote, 1958, The American Journal of Digestive Diseases.

Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?

R. Westendorp, J. Vandenbroucke, W. F. M. Potshuma, 1994, BMJ.

Estimated age- and sex-specific incidence and prevalence of dopamine agonist-treated hyperprolactinemia.

P. Souverein, J. Vandenbroucke, O. Dekkers, 2009, The Journal of clinical endocrinology and metabolism.

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

F R Rosendaal, J. Vandenbroucke, F. Rosendaal, 2009, BMJ : British Medical Journal.

The tortuous history of the implementation of early ambulation after delivery

J. Vandenbroucke, K. V. van Stralen, C. Doggen, 2007, Journal of the Royal Society of Medicine.

Unexplained fever: seven year experience.

J. Vandenbroucke, R. Wouters, L. Eyckmans, 1973, Acta clinica Belgica.

Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users who are carriers of hereditary prothrombotic conditions

S. D. de Bruijn, J. Vandenbroucke, J. Stam, 1998 .

Mortality in hereditary antithrombin-III deficiency—1830 to 1989

D. Hommes, F. Rosendaal, H. Buller, 1991, The Lancet.

Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit

J. Vandenbroucke, J. Vandenbroucke, C. Vandenbroucke-Grauls, 1991, The Lancet.

Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations.

A. Cats, H. Valkenburg, J. Vandenbroucke, 1989, Annals of the rheumatic diseases.

Experience with multiple control groups in a large population-based case–control study on genetic and environmental risk factors

F. R. Rosendaal, S. le Cessie, F. Rosendaal, 2010, European Journal of Epidemiology.

Selective decontamination of digestive tract

V. Torri, A. Liberati, L. Brazzi, 1991, The Lancet.

Comparison of the automated Bactec NR-660 with a conventional blood culture system

J. Hermans, J. Vandenbroucke, R. Mouton, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

Mortality caused by stomach cancer after remote partial gastrectomy for benign conditions: 40 years of follow up of an Amsterdam cohort of 2633 postgastrectomy patients.

J. Vandenbroucke, T. Stijnen, G. Tytgat, 1988, Gut.

Salmonella bacteremia

J. Vandenbroucke, L. Eyckmans, R. Vrooninks, 1974, Infection.

Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)

P. Reitsma, J. Vandenbroucke, F. Rosendaal, 1995, Blood.

Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption.

J P Vandenbroucke, A. Cats, B. Dijkmans, 1990, Annals of the rheumatic diseases.

Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients.

P. Reitsma, J. Vandenbroucke, F. Rosendaal, 1996, Blood.

Gene-Gene and Gene-Environment Interactions Determine Risk of Thrombosis in Families With Inherited Antithrombin Deficiency

E. Briët, J. Vandenbroucke, F. Rosendaal, 1999 .

Survival in families with hereditary protein C deficiency, 1820 to 1993

J. Vandenbroucke, F. Rosendaal, C. Allaart, 1995, BMJ.

Oral Contraceptives and Thrombotic Disease: Risk of Venous Thromboembolism

J. Vandenbroucke, F. Rosendaal, J. Vandenbroucke, 1997, Thrombosis and Haemostasis.

Effects of indomethacin on intragastric pH and meal‐stimulated serum gastrin secretion in rheumatoid arthritis patients

B. Dijkmans, J. Vandenbroucke, C. Lamers, 1993, Alimentary pharmacology & therapeutics.

Pregnancy and the risk of developing rheumatoid arthritis.

A. Cats, B. Dijkmans, J. Vandenbroucke, 1990, Arthritis and rheumatism.

Are atypical nevi a risk factor for uveal melanoma? A case-control study.

J. Vandenbroucke, W. Bergman, M. Jager, 1994, The Journal of investigative dermatology.

Immunoadsorption in patients with haemolytic uraemic syndrome

J. Vandenbroucke, A. Roukens, 2012, The Lancet.